SciHub
文献互助
期刊查询
一搜即达
科研导航
交流社区
登录
注册
发布
文献
求助
首页
我的求助
捐赠本站
qian
Lv3
290 积分
2021-07-19 加入
最近求助
最近应助
互助留言
Antibody-mediated delivery of chimeric protein degraders which target estrogen receptor alpha (ERα)
4天前
已完结
SC912 inhibits AR-V7 activity in castration-resistant prostate cancer by targeting the androgen receptor N-terminal domain
7天前
已完结
Structure–Activity Relationship (SAR) Studies of Novel Monovalent AR/AR-V7 Dual Degraders with Potent Efficacy against Advanced Prostate Cancer
8天前
已完结
What influences the activity of Degrader−Antibody conjugates (DACs)
12天前
已完结
Degrader-antibody conjugates
12天前
已完结
Peptide–Drug Conjugates: An Emerging Direction for the Next Generation of Peptide Therapeutics
25天前
已完结
Characteristics of anticancer activity of CBP/p300 inhibitors – Features of their classes, intracellular targets and future perspectives of their application in cancer treatment
28天前
已完结
Discovery of CBPD-409 as a Highly Potent, Selective, and Orally Efficacious CBP/p300 PROTAC Degrader for the Treatment of Advanced Prostate Cancer
28天前
已完结
Current status of PSMA-targeted imaging and therapy
1个月前
已完结
Design, Synthesis, and Biological Evaluation of 1-(Indolizin-3-yl)ethan-1-ones as CBP Bromodomain Inhibitors for the Treatment of Prostate Cancer
1个月前
已完结
没有进行任何应助
感谢,速度真快,帮大忙了
7天前
感谢,帮大忙了
12天前
感谢,速度真快
25天前
感谢,帮大忙了,点赞
1个月前
感谢,点赞
1个月前
感谢,速度真快,点赞
4个月前
感谢,帮大忙了
4个月前
感谢
4个月前
感谢,速度真快,点赞
4个月前
感谢,速度真快,帮大忙了
7个月前
最近帖子
最近评论
没有发布任何帖子
没有发布任何评论